Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
highly purified urinary follicle stimulating hormone + cetrorelix
- Development stage
- Unknown
- Lead developer
- Merck KGaA
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Subcutaneous
01
Overview
This combination regimen is used in controlled ovarian hyperstimulation (COH) protocols for in vitro fertilization (IVF), specifically studied by the Riyadh Fertility and Reproductive Health center for women with poor ovarian response. The regimen consists of highly purified urinary follicle stimulating hormone (HPuFSH), which provides exogenous FSH to stimulate the development of multiple ovarian follicles, and a gonadotropin-releasing hormone (GnRH) antagonist, cetrorelix. Cetrorelix acts by competitively blocking GnRH receptors in the pituitary gland, thereby preventing premature luteinizing hormone (LH) surges that could lead to untimely ovulation. This specific protocol is often evaluated as a standard of care against which adjunctive therapies, such as growth hormone (somatropin), are tested to improve clinical outcomes in patients identified as "poor responders."
- Brand names
- FostimonCetrotide
- Other names
- HPuFSH + GnRH antagonistHPuFSH/GnRH antagonisthighly purified urinary FSH + GnRH antagonist
02
Targets
FSHR (Follicle-stimulating hormone receptor)GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on highly purified urinary follicle stimulating hormone + cetrorelix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on highly purified urinary follicle stimulating hormone + cetrorelix.